Cargando…
A New In Vivo Zebrafish Bioassay Evaluating Liver Steatosis Identifies DDE as a Steatogenic Endocrine Disruptor, Partly through SCD1 Regulation
Non-alcoholic fatty liver disease (NAFLD), which starts with liver steatosis, is a growing worldwide epidemic responsible for chronic liver diseases. Among its risk factors, exposure to environmental contaminants, such as endocrine disrupting compounds (EDC), has been recently emphasized. Given this...
Autores principales: | Le Mentec, Hélène, Monniez, Emmanuelle, Legrand, Antoine, Monvoisin, Céline, Lagadic-Gossmann, Dominique, Podechard, Normand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959061/ https://www.ncbi.nlm.nih.gov/pubmed/36835354 http://dx.doi.org/10.3390/ijms24043942 |
Ejemplares similares
-
Membrane Remodeling as a Key Player of the Hepatotoxicity Induced by Co-Exposure to Benzo[a]pyrene and Ethanol of Obese Zebrafish Larvae
por: Imran, Muhammad, et al.
Publicado: (2018) -
Benzo(a)pyrene triggers desensitization of β2-adrenergic pathway
por: Mayati, Abdullah, et al.
Publicado: (2017) -
Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivo
por: Bucher, Simon, et al.
Publicado: (2018) -
Endocrine disruptors also function as nervous disruptors and can be renamed endocrine and nervous disruptors (ENDs)
por: Seralini, Gilles-Eric, et al.
Publicado: (2021) -
Endocrine Disruptors and Obesity
por: Darbre, Philippa D.
Publicado: (2017)